Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeioma: use of "progression-free survival 2" as a clinical trial end-point

被引：21
作者：
Dimopoulos, Meletios A. [1 ]
Petrucci, Maria T. [2 ]
Foa, Robin [2 ]
Catalano, John [3 ]
Kropff, Martin [4 ]
Terpos, Evangelos [4 ]
Zhang, Jingshan [5 ]
Grote, Lara [5 ]
Jacques, Christian [5 ]
Palumbo, Antonio [6 ]
机构：
[1] Univ Athens, Sch Med, GR-10679 Athens, Greece
[2] Univ Roma La Sapienza, Rome, Italy
[3] Monash Univ, Frankston Hosp, Clayton, Vic 3800, Australia
[4] Univ Munster, Munster, Germany
[5] Celgene Corp, Summit, NJ USA
[6] Univ Turin, I-10124 Turin, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷 / 08期
关键词：
PFS2; MM-015; lenalidomide; maintenance; newly diagnosed multiple myeloma (NDMM); STEM-CELL TRANSPLANTATION; LENALIDOMIDE;
D O I：
10.3324/haematol.2014.120790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E328 / E330
页数：3
相关论文
共 15 条
  • [1] [Anonymous], 2012, GUID EV ANT MED PROD
  • [2] Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
    Attal, Michel
    Lauwers-Cances, Valerie
    Marit, Gerald
    Caillot, Denis
    Moreau, Philippe
    Facon, Thierry
    Stoppa, Anne Marie
    Hulin, Cyrille
    Benboubker, Lofti
    Garderet, Laurent
    Decaux, Olivier
    Leyvraz, Serge
    Vekemans, Marie-Christiane
    Voillat, Laurent
    Michallet, Mauricette
    Pegourie, Brigitte
    Dumontet, Charles
    Roussel, Murielle
    Leleu, Xavier
    Mathiot, Claire
    Payen, Catherine
    Avet-Loiseau, Herve
    Harousseau, Jean-Luc
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) : 1782 - 1791
  • [3] Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
    Benboubker, Lotfi
    Dimopoulos, Meletios A.
    Dispenzieri, Angela
    Catalano, John
    Belch, Andrew R.
    Cavo, Michele
    Pinto, Antonello
    Weisel, Katja
    Ludwig, Heinz
    Bahlis, Nizar
    Banos, Anne
    Tiab, Mourad
    Delforge, Michel
    Cavenagh, Jamie
    Geraldes, Catarina
    Lee, Je-Jung
    Chen, Christine
    Oriol, Albert
    de la Rubia, Javier
    Qiu, Lugui
    White, Darrell J.
    Binder, Daniel
    Anderson, Kenneth
    Fermand, Jean-Paul
    Moreau, Philippe
    Attal, Michel
    Knight, Robert
    Chen, Guang
    Van Oostendorp, Jason
    Jacques, Christian
    Ervin-Haynes, Annette
    Avet-Loiseau, Herve
    Hulin, Cyrille
    Facon, Thierry
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (10) : 906 - 917
  • [4] Progression-Free Survival: Meaningful or Simply Measurable?
    Booth, Christopher M.
    Eisenhauer, Elizabeth A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (10) : 1030 - 1033
  • [5] Preemptive Rituximab Infusions Efficiently Prevent Relapses In Acquired Thrombotic Thrombocytopenic Purpura. Experience Of The French Thrombotic Microangiopathies Reference Center
    Hie, Miguel
    Gay, Julie
    Galicier, Lionel
    Provot, Francois
    Malot, Sandrine
    Poullin, Pascale
    Bonmarchand, Guy
    Wynckel, Alain
    Benhamou, Ygal
    Vanhille, Philippe
    Bordessoule, Dominique
    Vernant, Jean-Paul
    Veyradier, Agnes
    Coppo, Paul
    [J]. BLOOD, 2013, 122 (21)
  • [6] Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
    McCarthy, Philip L.
    Owzar, Kouros
    Hofmeister, Craig C.
    Hurd, David D.
    Hassoun, Hani
    Richardson, Paul G.
    Giralt, Sergio
    Stadtmauer, Edward A.
    Weisdorf, Daniel J.
    Vij, Ravi
    Moreb, Jan S.
    Callander, Natalie Scott
    Van Besien, Koen
    Gentile, Teresa
    Isola, Luis
    Maziarz, Richard T.
    Gabriel, Don A.
    Bashey, Asad
    Landau, Heather
    Martin, Thomas
    Qazilbash, Muzaffar H.
    Levitan, Denise
    McClune, Brian
    Schlossman, Robert
    Hars, Vera
    Postiglione, John
    Jiang, Chen
    Bennett, Elizabeth
    Barry, Susan
    Bressler, Linda
    Kelly, Michael
    Seiler, Michele
    Rosenbaum, Cara
    Hari, Parameswaran
    Pasquini, Marcelo C.
    Horowitz, Mary M.
    Shea, Thomas C.
    Devine, Steven M.
    Anderson, Kenneth C.
    Linker, Charles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) : 1770 - 1781
  • [7] The genetic architecture of multiple myeloma
    Morgan, Gareth J.
    Walker, Brian A.
    Davies, Faith E.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (05) : 335 - 348
  • [8] The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis
    Morgan, Gareth J.
    Gregory, Walter M.
    Davies, Faith E.
    Bell, Sue E.
    Szubert, Alexander J.
    Brown, Julia M.
    Coy, Nuria N.
    Cook, Gordon
    Russell, Nigel H.
    Rudin, Claudius
    Roddie, Huw
    Drayson, Mark T.
    Owen, Roger G.
    Ross, Fiona M.
    Jackson, Graham H.
    Child, J. Anthony
    [J]. BLOOD, 2012, 119 (01) : 7 - 15
  • [9] Palumbo A, 2014, J CLIN ONCOL, V32
  • [10] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
    Palumbo, Antonio
    Bringhen, Sara
    Larocca, Alessandra
    Rossi, Davide
    Di Raimondo, Francesco
    Magarotto, Valeria
    Patriarca, Francesca
    Levi, Anna
    Benevolo, Giulia
    Vincelli, Iolanda Donatella
    Grasso, Mariella
    Franceschini, Luca
    Gottardi, Daniela
    Zambello, Renato
    Montefusco, Vittorio
    Falcone, Antonietta Pia
    Omede, Paola
    Marasca, Roberto
    Morabito, Fortunato
    Mina, Roberto
    Guglielmelli, Tommasina
    Nozzoli, Chiara
    Passera, Roberto
    Gaidano, Gianluca
    Offidani, Massimo
    Ria, Roberto
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Boccadoro, Mario
    Cavo, Michele
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (07) : 634 - +
12